|
The leprosy
elimination programme is a successful model of well-functioning partnerships
of all the important stake-holders – The national governments, WHO, World
Bank, Bilateral/Multilateral donors and national/international NGOs (ILA,
ILEP). Another major contributing factor has been the free supply of leprosy
drugs to all endemic countries from 1995 to 2000 by The Nippon Foundation.
The Novartis Foundation for Sustainable Development
has assured the continuation of the free supply of leprosy drugs until 2010.
International
NGOs
The World Bank
Donors
The programme has demonstrated that strong public-private
coalitions built on wide ownership, equality of stakeholders, transparency of
governance, shared credit, and recognition of respective roles and
responsibilities goes a long way in achieving goals and success. There is
need to further strengthen these partnerships and involve new partners as we
progress from national to sub-national level elimination and further reduce
the burden of leprosy.
|
